From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

HealthDay News — For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to ...

Discover more about how nutrition and lifestyle interventions can improve the quality of life of patients with prostate ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

Please provide your email address to receive an email when new articles are posted on . Men assigned SBRT reported fewer adverse effects, but longer radiation courses may offer better biochemical ...

Among age-related ailments, cases of prostate-related problems are being reported with increasing frequency. Most concerning ...

Prostate Cancer Awareness Prostate-related health issues are becoming increasingly prevalent among older men, with prostate ...